Eli Lilly is worried that the Novo-Catalent deal could dent its ability to make drugs

, February 7, 2024
Pharma

Executives have concerns about Novo Holdings' purchase of contract manufacturer Catalent because Catalent helps produce certain Lilly products.

Novo Nordisk's parent to buy Catalent for $16.5B to boost Wegovy supply

, February 7, 2024
Pharma

Novo Nordisk parent company says its buying Catalent, a key manufacturing subcontractor of Wegovy, for $16.5 billion.

Medicare now negotiating price of drug that costs $7.1K in U.S. vs. $900 in Canada

, February 7, 2024
Pharma

Senate HELP Committee Chair Bernie Sanders (I-VT) issued the report ahead of this committee's hearing Thursday with the CEOs of the three drugmakers.

What a $200B blockbuster drug reveals about Big Pharma's playbook

, February 5, 2024
Pharma

AbbVie's success in navigating Humira's decline holds lessons for pharmaceutical companies, investors and policymakers.

J&J accused of mismanaging its employees' drug denefits

, February 5, 2024
Pharma

The novel lawsuit by a J&J worker alleges employees overpaid for some drugs.

As investors pile into psychedelics, idealism gives way to pharma economics

, February 5, 2024
Pharma

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions.

Pages